Enzymatic assay of opioid analgesic, tramadol, using horseradish peroxidase

• Autorzy: Sridevi N. , Srilakshmi C. , Alekya G. , Bala Sekaran C.
• Języki publikacji: EN

Abstrakty

EN

Three novel and sensitive enzymatic methods have been developed for the quantification of tramadol in pharmaceutical dosage forms. The proposed methods are based on the reaction of tramadol with 3-methylbenzothiazoline-2-one hydrazone (method A), aniline (method B) and aminoantipyrine in the presence of hydrogen peroxide and horseradish peroxidase to give colored complexes. The colored complexes obtained with 3-methylbenzothiazoline-2-one hydrazone, aniline and aminoantipyrine exhibit absorption maxima at 480 nm, 550 nm and 530 nm, respectively. Regression analysis of Beer’s plots showed good correlation for tramadol in the concentration range (μg/mL) 2-12 for the methods A & B and 4-24 for the method C. The experimental parameters were studied and optimized. The precision and accuracy of the methods were satisfactory. The proposed methods were successfully applied for the quantification of tramadol in 3 brands of commercially available tablet dosage forms. The results were compared satisfactorily with the official method.

Słowa kluczowe

EN

opioid; tramadol; horseradish peroxidase; enzymatic method

• Wydawca: -
• Czasopismo: International Letters of Natural Sciences
• Rocznik: 2014
• Tom: 11
• Numer: 1
• Opis fizyczny: p.69-84,fig.,ref.

Twórcy

autor

Sridevi N.

• Department of Science and Humanities, Siva Rama Krishna Institute of Technology, Enikepadu - 521 108, Andhra Pradesh, India

autor

Srilakshmi C.

• Department of Environmental Sciences, Dhanekula Institute of Engineering and Technology, Vijayawada - 521 139, Andhra Pradesh, India

autor

Alekya G.

• Department of Science and Humanities, NRI Institute of Technology, Pothavarappadu - 521211, Andhra Pradesh, India

autor

Bala Sekaran C.

• Department of Biotechnology, Jagarlamudi Kuppuswamy Choudary College, Guntur - 522 006, Andhra Pradesh, India

Bibliografia

• [1] P. Dayer, J. Desmeules, L. Collart, Drugs 53 (1997) 18-24.
• [2] K. S. Lewis, N. H. Han, American Journal of Health - System Pharmacy 54 (1997) 643-352.
• [3] L. Costa, F. Barros, F. Pedro, C. Dias, European Journal of Anaesthesiology 13 (1996 199-200. [4] F. Coluzzi, C. Mattia, Therapeutics and Clinical Risk Management 3 (2007) 819-829. [5] AS. Stephan, Therapeutics and Clinical Risk Management 3 (2007) 717-723.
• [6] L. Adler, C. McDonald, C. O’Brien, M. Wilson, The Journal of Rheumatology 29 (2002) 2196-2199.
• [7] G. Mongin, Expert Review of Neurotherapeutics 7 (2007) 1775-1784.
• [8] H. H. Hennies, E. Friderichs, J. Schneider, Arzneimittel-Forschung 38 (1988) 877-880.
• [9] M. C. Frink, H. H. Hennies, W. Englberger, M. Haurand, B. Wilffert, Arzneimittel-Forschung 46 (1996) 1029-1036.
• [10] P. Dayer, J. Desmeules, L. Collart, Drugs 53 (1997) 18-24.
• [11] B. Driessen, W. Reimann, British Journal of Pharmacology 105 (1992) 147-151.
• [12] T. A. Bamigbade, C. Davidson, R. M. Langford, J. A. Stamford, British Journal of Anaesthesia 79 (1997) 352.356.
• [13] W. Reimann, F. Schneider, European Journal of Pharmacology 349 (1998) 199-203.
• [14] M. Gobbi, M. Moia, L. Pirona, I. Ceglia, M. Reyes-Parada, C. Scorza, T. Mennini, Journal of Neurochemistry 82 (2002) 1435-1443.
• [15] European Pharmacopoeia, 5th Edi., European Department for the Quality of Medicines within the Council of Europe, Strasbourg, 2005, p. 2607.
• [16] H. E. Abdellatef, M. M. El-Henawee, H. M. El-Sayed, M.M. Ayad, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 65 (2006) 1087-1092.
• [17] A. Küçüka, Y. Kadıoğlub, II Farmaco 60 (2005) 163-169.
• [18] A. Curticapean, D. Munteana, M. Curticapeana, M. Dogarua, C. Vari, Journal of Biochemical and Biophysical Methods 70 (2008) 1304-1312.
• [19] Y. Geng-Chang, S. Ming-Thau, Y. Chia-Lin, W. Ya-Wen, L. Cheng-Hsiung, H. Hsiu-O., Journal of Chromatography B: Biomedical Sciences and Applications 723 (1999) 247-253.
• [20] S. H. Gan, R. Ismail, W. A. Wan Adnan, Z. Wan, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 772 (2008) 123-129.
• [21] Y. H. Ardakani, Md. Reza Rouini, Journal of Pharmaceutical and Biomedical Analysis 44 (2007) 1168-1173.
• [22] M. Nobilis, J. Kopecký, J. Kvtina, J. Chládek, Z. Svoboda, V. Voíek, F. Perlík, M. Pour, J. Kune, Journal of Chromatography A 949 (2002) 11-22.
• [23] M. A. Campanero, E. García-Quetglas, B. Sádaba, J. R. Azanza, Journal of Chromatography 1031 (2004) 219-228..
• [24] M. De Leo, M. Giorgi, G. Saccomanni, C. Manera, A. Braca, C:\pmid:19072864Rapid Communications in Mass Spec trometry 23 (2009) 228-236.
• [25] H. M. Abu-Shawish, N. A. Ghalwa, F. R. Zaggout, S.M. Saadeh, A.R. Al-Dalou, A.A. Abou Assi, Biochemical Engineering Journal 48 (2010) 237-245.
• [26] M. R. Ganjali, T. Razavi, F. Faridbod, S. Riahi, P. Norouzi, Current Pharmaceutical Analysis 5 (2009) 28-33.
• [27] EMPJ. Garrido, JMPJ. Garrido, F. Borges, C. Delerue-Matos, Journal of Pharmaceutical and Biomedical Analysis 32 (2003) 975-981.
• [28] M. Merslavič, L. Zupančič-Kralj, Journal of Chromatography B: Biomedical Sciences and Applications 693 (1997) 222-227.
• [29] Y. F. Sha, S. Shen, G. L. Duan, Journal of Pharmaceutical and Biomedical Analysis 37 (2005) 143-147.
• [30] Q. Tao, D. J. Stone, M. R. Borenstein, V. Jean-Bart, E. E. Codd, T.P. Coogan, D. Desai-Krieger, S. Liao, RB. Raffa, Journal of Chromatography B: Biomedical Science Applications 763 (2001) 165-171.
• [31] S. N. Meyyanathan, P. Kumar, B. Suresh, Journal of Separation Science 26 (2003) 1359-1362.
• [32] K. Venkateshwarlu, Y. N. Reddy, K. Srisailam, V. Rajkumar, M. G. Pai, Current Trends in Biotechnology and Pharmacy 2 (2008) 421-425.
• [33] J. Krzek, M. Starek, Biomedical Chromatography 18 (2004) 589-599.
• [34] H. E. Abdellatef, Journal of Pharmaceutical and Biomedical Analysis 29 (2002) 835-842.
• [35] A. Kumar, S. Nanda, R. Chomwal, The Indian Pharmacist 8 (2010) 85-87.
• [36] R. Kalaichelvi, E. Jayachandran, Research Journal of Pharmacy and Technology 3 (2010) 1096-1099
• [37] Validation of Analytical Procedures, Methodology, International Conference on Harmonization (ICH): Text and Methodology Q2 (R 1): Complementary Guideline on Methodology dated 06 November 1996: incorporated in November 2005, London.
• [38] H. U. Bergmeyer, Methods of Enzymic Analysis, Academic Press, 1965, p. 895.
• [39] P. Nagaraja, A. Shivakumar, A. K. Shrestha, Analytical Biochemistry 395 (2009) 231-236.
• [40] S. Leonardo, S. Sara, D. A. Igor, G. P. Pier, Enzyme and Microbial Technology 22 (1998) 656-661.
• [41] Z. Huixian, K. E. Taylor, Chemosphere 28 (1994) 1807-1817.
• [42] C. B. Sekaran, C. R., Babu, B. P. Kumar, D. R. Shankar, Journal of Pure and Applied Microbiology 2 (2008) 257-259.
• [43] C. B. Sekaran, S. V. Saradhi, Biotechnology Biosciences Research Asia 5 (2008) 258-261.
• [44] C. B. Sekaran, S. V. Saradhi, B. P. Kumar, Ch. Srilakshmi, Asian Journal of Chemistry 21 (2009) 6647-6650.
• [45] A. P. Rani, C. B. Sekaran, Ch. Srilakshmi, Biomedical and Pharmacology Journal 2 (2009) 91-94.